Molecular breast imaging (MBI) is increasingly recognized as a critical tool for breast cancer diagnosis, especially in dense-breasted women, where traditional mammography often fails. Using only a small amount of radioactive tracer and a special gamma camera to identify cancerous cells, MBI provides clearer imaging results for certain patient groups. Being non-invasive, relatively less expensive compared to an MRI, and effective at an early stage of detection, these are few of the important aspects contributing toward the growth of the market.
Factors such as increasing number of breast cancer cases, improvement in health care infrastructure, and rising awareness towards early detection is driving the growth of MBI market globally. Other innovations in the field of nuclear medicine imaging and improving access to MBI systems across hospitals and diagnostic centers further support the penetration of the market. MBI is fast becoming the method of choice for breast imaging as screening guidelines expand and more women seek personalized and accurate diagnostics.
The market is projected to grow at a compound annual growth rate (CAGR) of 4.4% from 2025 to 2035, increasing from USD 637 Million in 2025 to USD 970.24 Million by 2035.
Metric Overview
| Metric | Value |
|---|---|
| Market Size (2025) | USD 637 Million |
| Market Value (2035) | USD 970.24 Million |
| CAGR (2025 to 2035) | 4.4% |
North America is a dominator in the molecular breast imaging market with its well-established healthcare infra along with a robust presence of diagnostic imaging companies and favourable reimbursement policies. The country that continues to lead the market is the United States due to a rise in breast cancer prevalence and national awareness campaigns backing proactive screenings.
Europe shows healthy growth in the MBI market which is further supported by increasing adoption of new imaging techniques and government initiatives in breast cancer screening. With such countries as Germany, France, and Sweden, MBI is now coming into clinical practice alongside mammography for women having dense breast tissue.
Asia-Pacific is set to realize maximum growth as compared to other regional markets due to constant and increasing investments in health technologies, expansion of diagnostic infrastructures, and improving awareness about breast cancer screening. Therefore, demand for cost-effective imaging modalities is increasing in China, India, and Japan, making MBI become a potential method for better cancer detection in this part of the world.
High Equipment Costs and Limited Accessibility
An important hurdle posed by MBI capital costs constitutes a large interest to smaller healthcare facilities and institutions in limited-resource settings. Therefore, it remains a hindrance to the MBI's wider uptake in developing regions with limited budgets for health care.
Radiation Exposure Concerns
MBI results in better imaging of dense breast tissues, it involves the injection of radioactive tracers into patients. The fear of the radiation dose, especially with repeated screenings, can dampen patient and provider acceptance of MBI over other modalities.
Advancements in Imaging Technology
The improvement in detective sensitivity and image resolution acts as a gradual conversion factor of MCI in diagnosis. The recent advancement has made MBI more tempting in early detection of cancer in dense tissues poorly performed by conventional mammography.
Growing Emphasis on Early Detection
The rising awareness of the importance of early detection of breast cancer has created demand for more precise diagnostic tools. MBI, through its unique ability to detect some tumours otherwise occult on mammograms, has therefore emerged as a very valuable adjunct imaging technique.
| Market Shift | 2020 to 2024 Trends |
|---|---|
| Technology Adoption | Limited to specialized centers |
| Regulatory Approvals | Slow and region-specific |
| Cost Considerations | High equipment and operational costs |
| Clinical Guidelines | MBI as adjunct in specific cases |
| Patient Awareness | Limited awareness among patients |
| Research and Development | Focus on improving image quality |
| Market Shift | 2025 to 2035 Projections |
|---|---|
| Technology Adoption | Broader adoption across various healthcare settings |
| Regulatory Approvals | Streamlined processes facilitating faster approvals |
| Cost Considerations | Technological advancements leading to cost reductions |
| Clinical Guidelines | Potential inclusion in standard screening protocols |
| Patient Awareness | Increased education leading to higher acceptance and demand |
| Research and Development | Emphasis on reducing radiation dose and enhancing patient comfort |
The USA market is attributing its growth to the extremely advanced medical imaging technology and high awareness level on screening for breast cancer. Also present supportive reimbursement policies by the critical medical device manufacturers and their strong presence are also contributing significantly to the increasing MBI adoption in hospitals, diagnostic centers, and specialty clinics.
| Country | CAGR (2025 to 2035) |
|---|---|
| United States | 4.6% |
The increase in the demand for advanced diagnostic tools such as MBI can also be attributed to government investment into health and strong national screening programs in the United Kingdom. The strengthening of academic collaborations and public-private partnerships also help the advancement of further innovation in imaging technologies and greater accuracy in diagnosis, particularly for the high-risk patient groups in early detection efforts.
| Country | CAGR (2025 to 2035) |
|---|---|
| United Kingdom | 4.2% |
The harmonized cancer screening policies in the European Union, the aging population, and the increasing interest for accurate diagnostic processes would be promising for these markets. Major countries such as Germany, France, and Italy are spending enormously on next-generation imaging solutions and making the European Union a strong market for MBI technology in early breast cancer detection.
| Region | CAGR (2025 to 2035) |
|---|---|
| European Union | 4.3% |
The rapid aging of the population and the growing cancer screening programs have been propelling the MBI market in Japan. Innovations in technology from domestic manufacturers, along with the government's support for healthcare, bring forth the early diagnosis. Furthermore, cultural belief in regular health check-ups leads to an increase in the use of enhanced new imaging devices, like MBI, in cities.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 4.4% |
In South Korea, the molecular breast imaging market is expanding due to increasing government healthcare initiatives, growing public awareness about breast cancer screening, and the need for high-sensitivity diagnostic tools. Adoption is also supported by investments in nuclear medicine infrastructure and collaboration between hospitals and medical imaging companies.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 4.5% |
| By Modality | Market Share (2025) |
|---|---|
| Dual Head Camera | 63.5% |
In the MBI industry, dual-head gamma cameras are expected to be the market leader in 2025, holding 63.5% of the market share. These systems have better resolution and sensitivity than a single-head and therefore can detect even the smallest lesions better in women with dense breast parenchyma. With dual detectors that acquire simultaneous images from opposing views, they reduce patient scanning time and ensure comfort during screening and diagnosis.
With improved reliability of diagnosis, they are particularly useful for detecting cancers that may not be seen on conventional mammography. The globally rising incidence of breast cancer, coupled with a focus on early detection and personal imaging, has made hospitals and diagnostic centers embrace dual-head MBI systems for accurate and reliable screening even more.
| By Application | Market Share (2025) |
|---|---|
| Diagnosis | 58.7% |
The segment of diagnosis applications is anticipated to rule the MBI market in terms of shares amounting to 58.7% by the year 2025. MBI assumes significance as an added adjunct diagnostic tool for the patients with inconclusive mammograms or results from ultrasound examinations, as it provided better lesion detectability, especially with dense breast tissues. It's unlike the traditional imaging modality that is not functional but rather gives imaging via radiotracer uptakes for better visualization of cancer activity.
Its specificity is high enough to reduce false positives and unnecessary biopsies. As clinicians are further moving toward imaging for treatment planning, especially high-risk patients, the application of MBI as a diagnostic tool is also becoming more popular. The expanding coverage for reimbursement and continued research on the development of new radiotracers will only make it a stronger candidate in the landscape of diagnostic imaging.
The growing incidence of breast cancer around the world combined with the increasing demand for advanced diagnostics techniques has aided the molecular breast imaging (MBI) market in realizing healthy growth. Enhanced sensitivity for detecting tumours is offered by MBI, especially in women with dense breast tissues, for whom mammography has been less effective.
Advancements in technology, dual-head gamma cameras, and improved radiotracers presently propel the adoption of the MBI system. The region with the highest growth currently in this domain is North America, thanks to the well-developed healthcare infrastructure, extensive R&D activities, and a greater amount of dollars within the health care system.
Market Share Analysis by Key Players
| Company Name | Estimated Market Share (%) |
|---|---|
| GE Healthcare | 20-25% |
| Siemens Healthineers | 15-20% |
| Hologic, Inc. | 10-15% |
| Koninklijke Philips N.V. | 8-12% |
| Canon Medical Systems Corporation | 5-10% |
| Others | 20-30% |
| Company Name | Key Offerings/Activities (with Year) |
|---|---|
| GE Healthcare | Offers the Discovery NM750b MBI system, featuring high-resolution detectors for improved lesion detection. |
| Siemens Healthineers | Provides the Symbia Intevo MBI system, integrating advanced imaging technologie s for precise diagnostics. |
| Hologic, Inc. | Develops the Selenia Dimensions system with molecular imaging capabilities, enhancin g breast cancer detection. |
| Koninklijke Philips N.V. | Introduced the BrightView XCT system, combining molecular imaging with CT for com prehensive breast imaging. |
| Canon Medical Systems Corporation | Offers the Celesteion PET/CT system, facilitating molecular imaging for oncology applications, including breast cancer. |
Key Market Insights
GE Healthcare (20-25%)
With its Discovery NM750b system, noted for high-resolution detectors and advanced imaging capability in aiding early detection of breast cancer, GE Healthcare leads the MBI market.
Siemens Healthineers (15-20%)
Siemens Healthineers has a market share of 15-20%. For example, its Symbia Intevo ensures enhanced patient outcomes through accurate diagnostics by the combination of advanced technology and molecular imaging.
Hologic Inc. (10-15%)
This Selenia Dimensions system from Hologic is based on features of molecular imaging that will facilitate enhancements of breast cancer detection, especially in women with dense breast tissue.
Koninklijke Philips N.V. (8-12%)
The BrightView XCT of Philips integrates molecular imaging with CT to offer a comprehensive breast imaging solution that enhances the accuracy of diagnosis.
Canon Medical Systems Corporation (5-10%)
The Celesteion PET/CT of Canon performs molecular imaging for oncology applications, including breast cancer, thus providing comprehensive support for precise diagnosis and treatment planning.
Other Key Players (20-30% Combined)
Table 01: Global Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Modality
Table 02: Global Market Volume (Units) Analysis and Opportunity Assessment 2017 to 2033, By Modality
Table 03: Global Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Application
Table 04: Global Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By End User
Table 05: Global Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Region
Table 06: Global Market Volume (Units) Analysis and Opportunity Assessment 2017 to 2033, By Region
Table 07: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
Table 08: North America Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Modality
Table 09: North America Market Volume (Units) Analysis and Opportunity Assessment 2017 to 2033, By Modality
Table 10: North America Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Application
Table 11: North America Market Value (US$ Million) Analysis- and Opportunity Assessment 2017 to 2033, By End User
Table 12: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
Table 13: Latin America Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Modality
Table 14: Latin America Market Volume (Units) Analysis and Opportunity Assessment 2017 to 2033, By Modality
Table 15: Latin America Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Application
Table 16: Latin America Market Value (US$ Million) Analysis- and Opportunity Assessment 2017 to 2033, By End User
Table 17: Europe Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
Table 18: Europe Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Modality
Table 19: Europe Market Volume (Units) Analysis and Opportunity Assessment 2017 to 2033, By Modality
Table 20: Europe Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Application
Table 21: Europe Market Value (US$ Million) Analysis- and Opportunity Assessment 2017 to 2033, By End User
Table 22: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
Table 23: South Asia Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Modality
Table 24: South Asia Market Volume (Units) Analysis and Opportunity Assessment 2017 to 2033, By Modality
Table 25: South Asia Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Application
Table 26: South Asia Market Value (US$ Million) Analysis- and Opportunity Assessment 2017 to 2033, By End User
Table 27: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
Table 28: East Asia Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Modality
Table 29: East Asia Market Volume (Units) Analysis and Opportunity Assessment 2017 to 2033, By Modality
Table 30: East Asia Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Application
Table 31: East Asia Market Value (US$ Million) Analysis- and Opportunity Assessment 2017 to 2033, By End User
Table 32: Oceania Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
Table 33: Oceania Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Modality
Table 34: Oceania Market Volume (Units) Analysis and Opportunity Assessment 2017 to 2033, By Modality
Table 35: Oceania Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Application
Table 36: Oceania Market Value (US$ Million) Analysis- and Opportunity Assessment 2017 to 2033, By End User
Table 37: Middle East and Africa Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
Table 38: Middle East and Africa Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Modality
Table 39: Middle East and Africa Market Volume (Units) Analysis and Opportunity Assessment 2017 to 2033, By Modality
Table 40: Middle East and Africa Market Value (US$ Million) Analysis and Opportunity Assessment 2017 to 2033, By Application
Table 41: Middle East and Africa Market Value (US$ Million) Analysis- and Opportunity Assessment 2017 to 2033, By End User
Figure 01: Global Market Value Share, By Modality, 2023 (E)
Figure 02: Global Market Value Share, By Application, 2023 (E)
Figure 03: Global Market Value Share, By End User, 2023 (E)
Figure 04: Global Market Value Share, By Region, 2023 (E)
Figure 05: Global Market Volume Analysis (US$ Million), 2017 to 2022
Figure 06: Global Market Volume Forecast (US$ Million), 2023 to 2033
Figure 07: Single Head Gamma Camera, Average Selling Price by Region, Per Unit (US$), 2022
Figure 08: Single Head Gamma Camera, Average Selling Price by Region, Per Unit (US$), 2033
Figure 09: Dual Head Camera, Average Selling Price by Region, Per Unit (US$), 2022
Figure 10: Dual Head Camera, Average Selling Price by Region, Per Unit (US$), 2033
Figure 11: Global Market Value Analysis (US$ Million), 2017 to 2022
Figure 12: Global Market Value Forecast (US$ Million), 2023 to 2033
Figure 13: Global Market Absolute $ Opportunity, 2023 to 2033
Figure 14: Global Market Share Analysis (%), By Modality, 2023 and 2033
Figure 15: Global Market Y-o-Y Analysis (%), By Modality, 2023 to 2033
Figure 16: Global Market Attractiveness Analysis by Modality, 2023 to 2033
Figure 17: Global Market Share Analysis (%), By Application, 2023 and 2033
Figure 18: Global Market Y-o-Y Analysis (%), By Application, 2023 to 2033
Figure 19: Global Market Attractiveness Analysis by Application, 2023 to 2033
Figure 20: Global Market Share Analysis (%), By End User, 2023 and 2033
Figure 21: Global Market Y-o-Y Analysis (%), By End User, 2023 to 2033
Figure 22: Global Market Attractiveness Analysis by End User, 2023 to 2033
Figure 23: Global Market Share Analysis (%), By Region, 2023 and 2033
Figure 24: Global Market Y-o-Y Analysis (%), By Region, 2023 to 2033
Figure 25: Global Market Attractiveness Analysis by Region, 2023 to 2033
Figure 26: North America Market Value Share, By Modality, 2023 (E)
Figure 27: North America Market Value Share, By Application, 2023 (E)
Figure 28: North America Market Value Share, By End User, 2023 (E)
Figure 29: North America Market Value Share, By Country, 2023 (E)
Figure 30: North America Market Value Analysis (US$ Million), 2017 to 2022
Figure 31: North America Market Value Forecast (US$ Million), 2023 to 2033
Figure 32: North America Market Attractiveness Analysis by Modality, 2023 to 2033
Figure 33: North America Market Attractiveness Analysis by Application, 2023 to 2033
Figure 34: North America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 35: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 36: United States Market Value Proportion Analysis, 2022
Figure 37: Global Vs. United States Growth Comparison, 2022 to 2033
Figure 38: United States Market Share Analysis (%) By Modality, 2022 and 2033
Figure 39: United States Market Share Analysis (%) By Application, 2022 and 2033
Figure 40: United States Market Share Analysis (%) By End User, 2022 and 2033
Figure 41: Canada Market Value Proportion Analysis, 2022
Figure 42: Global Vs. Canada. Growth Comparison, 2022 to 2033
Figure 43: Canada Market Share Analysis (%) By Modality, 2022 and 2033
Figure 44: Canada Market Share Analysis (%) By Application, 2022 and 2033
Figure 45: Canada Market Share Analysis (%) By End User, 2022 and 2033
Figure 46: Latin America Market Value Share, By Modality, 2023 (E)
Figure 47: Latin America Market Value Share, By Application, 2023 (E)
Figure 48: Latin America Market Value Share, By End User, 2023 (E)
Figure 49: Latin America Market Value Share, By Country, 2023 (E)
Figure 50: Latin America Market Value Analysis (US$ Million), 2017 to 2022
Figure 51: Latin America Market Value Forecast (US$ Million), 2023 to 2033
Figure 52: Latin America Market Attractiveness Analysis by Modality, 2023 to 2033
Figure 53: Latin America Market Attractiveness Analysis by Application, 2023 to 2033
Figure 54: Latin America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 55: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 56: Mexico Market Value Proportion Analysis, 2022
Figure 57: Global Vs Mexico Growth Comparison, 2022 to 2033
Figure 58: Mexico Market Share Analysis (%) By Modality, 2022 and 2033
Figure 59: Mexico Market Share Analysis (%) By Application, 2022 and 2033
Figure 60: Mexico Market Share Analysis (%) By End User, 2022 and 2033
Figure 61: Brazil Market Value Proportion Analysis, 2022
Figure 62: Global Vs. Brazil. Growth Comparison, 2022 to 2033
Figure 63: Brazil Market Share Analysis (%) By Modality, 2022 and 2033
Figure 64: Brazil Market Share Analysis (%) By Application, 2022 and 2033
Figure 65: Brazil Market Share Analysis (%) By End User, 2022 and 2033
Figure 66: Argentina Market Value Proportion Analysis, 2022
Figure 67: Global Vs Argentina Growth Comparison, 2022 to 2033
Figure 68: Argentina Market Share Analysis (%) By Modality, 2022 and 2033
Figure 69: Argentina Market Share Analysis (%) By Application, 2022 and 2033
Figure 70: Argentina Market Share Analysis (%) By End User, 2022 and 2033
Figure 71: Europe Market Value Share, By Modality, 2023 (E)
Figure 72: Europe Market Value Share, By Application, 2023 (E)
Figure 73: Europe Market Value Share, By End User, 2023 (E)
Figure 74: Europe Market Value Share, By Country, 2023 (E)
Figure 75: Europe Market Value Analysis (US$ Million), 2017 to 2022
Figure 76: Europe Market Value Forecast (US$ Million), 2023 to 2033
Figure 77: Europe Market Attractiveness Analysis by Modality, 2023 to 2033
Figure 78: Europe Market Attractiveness Analysis by Application, 2023 to 2033
Figure 79: Europe Market Attractiveness Analysis by End User, 2023 to 2033
Figure 80: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 81: United Kingdom Market Value Proportion Analysis, 2022
Figure 82: Global Vs. United Kingdom Growth Comparison, 2022 to 2033
Figure 83: United Kingdom Market Share Analysis (%) By Modality, 2022 and 2033
Figure 84: United Kingdom Market Share Analysis (%) By Application, 2022 and 2033
Figure 85: United Kingdom Market Share Analysis (%) By End User, 2022 and 2033
Figure 86: Germany Market Value Proportion Analysis, 2022
Figure 87: Global Vs. Germany Growth Comparison, 2022 to 2033
Figure 88: Germany Market Share Analysis (%) By Modality, 2022 and 2033
Figure 89: Germany Market Share Analysis (%) By Application, 2022 and 2033
Figure 90: Germany Market Share Analysis (%) By End User, 2022 and 2033
Figure 91: Italy Market Value Proportion Analysis, 2022
Figure 92: Global Vs. Italy Growth Comparison, 2022 to 2033
Figure 93: Italy Market Share Analysis (%) By Modality, 2022 and 2033
Figure 94: Italy Market Share Analysis (%) By Application, 2022 and 2033
Figure 95: Italy Market Share Analysis (%) By End User, 2022 and 2033
Figure 96: France Market Value Proportion Analysis, 2022
Figure 97: Global Vs France Growth Comparison, 2022 to 2033
Figure 98: France Market Share Analysis (%) By Modality, 2022 and 2033
Figure 99: France Market Share Analysis (%) By Application, 2022 and 2033
Figure 100: France Market Share Analysis (%) By End User, 2022 and 2033
Figure 101: Spain Market Value Proportion Analysis, 2022
Figure 102: Global Vs Spain Growth Comparison, 2022 to 2033
Figure 103: Spain Market Share Analysis (%) By Modality, 2022 and 2033
Figure 104: Spain Market Share Analysis (%) By Application, 2022 and 2033
Figure 105: Spain Market Share Analysis (%) By End User, 2022 and 2033
Figure 106: Russia Market Value Proportion Analysis, 2022
Figure 107: Global Vs Russia Growth Comparison, 2022 to 2033
Figure 108: Russia Market Share Analysis (%) By Modality, 2022 and 2033
Figure 109: Russia Market Share Analysis (%) By Application, 2022 and 2033
Figure 110: Russia Market Share Analysis (%) By End User, 2022 and 2033
Figure 111: Benelux Market Value Proportion Analysis, 2022
Figure 112: Global Vs Benelux Growth Comparison, 2022 to 2033
Figure 113: Benelux Market Share Analysis (%) By Modality, 2022 and 2033
Figure 114: Benelux Market Share Analysis (%) By Application, 2022 and 2033
Figure 115: Benelux Market Share Analysis (%) By End User, 2022 and 2033
Figure 116: Nordics Market Value Proportion Analysis, 2022
Figure 117: Global Vs Nordics Growth Comparison, 2022 to 2033
Figure 118: Nordics Market Share Analysis (%) By Modality, 2022 and 2033
Figure 119: Nordics Market Share Analysis (%) By Application, 2022 and 2033
Figure 120: Nordics Market Share Analysis (%) By End User, 2022 and 2033
Figure 121: South Asia Market Value Share, By Modality, 2023 (E)
Figure 122: South Asia Market Value Share, By Application, 2023 (E)
Figure 123: South Asia Market Value Share, By End User, 2023 (E)
Figure 124: South Asia Market Value Share, By Country, 2023 (E)
Figure 125: South Asia Market Value Analysis (US$ Million), 2017 to 2022
Figure 126: South Asia Market Value Forecast (US$ Million), 2023 to 2033
Figure 127: South Asia Market Attractiveness Analysis by Modality, 2023 to 2033
Figure 128: South Asia Market Attractiveness Analysis by Application, 2023 to 2033
Figure 129: South Asia Market Attractiveness Analysis by End User, 2023 to 2033
Figure 130: South Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 131: India Market Value Proportion Analysis, 2022
Figure 132: Global Vs. India Growth Comparison, 2022 to 2033
Figure 133: India Market Share Analysis (%) By Modality, 2022 and 2033
Figure 134: India Market Share Analysis (%) By Application, 2022 and 2033
Figure 135: India Market Share Analysis (%) By End User, 2022 and 2033
Figure 136: Indonesia Market Value Proportion Analysis, 2022
Figure 137: Global Vs. Indonesia Growth Comparison, 2022 to 2033
Figure 138: Indonesia Market Share Analysis (%) By Modality, 2022 and 2033
Figure 139: Indonesia Market Share Analysis (%) By Application, 2022 and 2033
Figure 140: Indonesia Market Share Analysis (%) By End User, 2022 and 2033
Figure 141: Malaysia Market Value Proportion Analysis, 2022
Figure 142: Global Vs. Malaysia Growth Comparison, 2022 to 2033
Figure 143: Malaysia Market Share Analysis (%) By Modality, 2022 and 2033
Figure 144: Malaysia Market Share Analysis (%) By Application, 2022 and 2033
Figure 145: Malaysia Market Share Analysis (%) By End User, 2022 and 2033
Figure 146: Thailand Market Value Proportion Analysis, 2022
Figure 147: Global Vs. Thailand Growth Comparison, 2022 to 2033
Figure 148: Thailand Market Share Analysis (%) By Modality, 2022 and 2033
Figure 149: Thailand Market Share Analysis (%) By Application, 2022 and 2033
Figure 150: Thailand Market Share Analysis (%) By End User, 2022 and 2033
Figure 151: Philippines Market Value Proportion Analysis, 2022
Figure 152: Global Vs. Philippines Growth Comparison, 2022 to 2033
Figure 153: Philippines Market Share Analysis (%) By Modality, 2022 and 2033
Figure 154: Philippines Market Share Analysis (%) By Application, 2022 and 2033
Figure 155: Philippines Market Share Analysis (%) By End User, 2022 and 2033
Figure 156: Vietnam Market Value Proportion Analysis, 2022
Figure 157: Global Vs. Vietnam Growth Comparison, 2022 to 2033
Figure 158: Vietnam Market Share Analysis (%) By Modality, 2022 and 2033
Figure 159: Vietnam Market Share Analysis (%) By Application, 2022 and 2033
Figure 160: Vietnam Market Share Analysis (%) By End User, 2022 and 2033
Figure 161: East Asia Market Value Share, By Modality, 2023 (E)
Figure 162: East Asia Market Value Share, By Application, 2023 (E)
Figure 163: East Asia Market Value Share, By End User, 2023 (E)
Figure 164: East Asia Market Value Share, By Country, 2023 (E)
Figure 165: East Asia Market Value Analysis (US$ Million), 2017 to 2022
Figure 166: East Asia Market Value Forecast (US$ Million), 2023 to 2033
Figure 167: East Asia Market Attractiveness Analysis by Modality, 2023 to 2033
Figure 168: East Asia Market Attractiveness Analysis by Application, 2023 to 2033
Figure 169: East Asia Market Attractiveness Analysis by End User, 2023 to 2033
Figure 170: East Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 171: China Market Value Proportion Analysis, 2022
Figure 172: Global Vs. China Growth Comparison, 2022 to 2033
Figure 173: China Market Share Analysis (%) By Modality, 2022 and 2033
Figure 174: China Market Share Analysis (%) By Application, 2022 and 2033
Figure 175: China Market Share Analysis (%) By End User, 2022 and 2033
Figure 176: Japan Market Value Proportion Analysis, 2022
Figure 177: Global Vs. Japan Growth Comparison, 2022 to 2033
Figure 178: Japan Market Share Analysis (%) By Modality, 2022 and 2033
Figure 179: Japan Market Share Analysis (%) By Application, 2022 and 2033
Figure 180: Japan Market Share Analysis (%) By End User, 2022 and 2033
Figure 181: South Korea Market Value Proportion Analysis, 2022
Figure 182: Global Vs South Korea Growth Comparison, 2022 to 2033
Figure 183: South Korea Market Share Analysis (%) By Modality, 2022 and 2033
Figure 184: South Korea Market Share Analysis (%) By Application, 2022 and 2033
Figure 185: South Korea Market Share Analysis (%) By End User, 2022 and 2033
Figure 186: Oceania Market Value Share, By Modality, 2023 (E)
Figure 187: Oceania Market Value Share, By Application, 2023 (E)
Figure 188: Oceania Market Value Share, By End User, 2023 (E)
Figure 189: Oceania Market Value Share, By Country, 2023 (E)
Figure 190: Oceania Market Value Analysis (US$ Million), 2017 to 2022
Figure 191: Oceania Market Value Forecast (US$ Million), 2023 to 2033
Figure 192: Oceania Market Attractiveness Analysis by Modality, 2023 to 2033
Figure 193: Oceania Market Attractiveness Analysis by Application, 2023 to 2033
Figure 194: Oceania Market Attractiveness Analysis by End User, 2023 to 2033
Figure 195: Oceania Market Attractiveness Analysis by Country, 2023 to 2033
Figure 196: Australia Market Value Proportion Analysis, 2022
Figure 197: Global Vs. Australia Growth Comparison, 2022 to 2033
Figure 198: Australia Market Share Analysis (%) By Modality, 2022 and 2033
Figure 199: Australia Market Share Analysis (%) By Application, 2022 and 2033
Figure 200: Australia Market Share Analysis (%) By End User, 2022 and 2033
Figure 201: New Zealand Market Value Proportion Analysis, 2022
Figure 202: Global Vs New Zealand Growth Comparison, 2022 to 2033
Figure 203: New Zealand Market Share Analysis (%) By Modality, 2022 and 2033
Figure 204: New Zealand Market Share Analysis (%) By Application, 2022 and 2033
Figure 205: New Zealand Market Share Analysis (%) By End User, 2022 and 2033
Figure 206: Middle East and Africa Market Value Share, By Modality, 2023 (E)
Figure 207: Middle East and Africa Market Value Share, By Application, 2023 (E)
Figure 208: Middle East and Africa Market Value Share, By End User, 2023 (E)
Figure 209: Middle East and Africa Market Value Share, By Country, 2023 (E)
Figure 210: Middle East and Africa Market Value Analysis (US$ Million), 2017 to 2022
Figure 211: Middle East and Africa Market Value Forecast (US$ Million), 2023 to 2033
Figure 212: Middle East and Africa Market Attractiveness Analysis by Modality, 2023 to 2033
Figure 213: Middle East and Africa Market Attractiveness Analysis by Application, 2023 to 2033
Figure 214: Middle East and Africa Market Attractiveness Analysis by End User, 2023 to 2033
Figure 215: Middle East and Africa Market Attractiveness Analysis by Country, 2023 to 2033
Figure 216: GCC Countries Market Value Proportion Analysis, 2022
Figure 217: Global Vs GCC Countries Growth Comparison, 2022 to 2033
Figure 218: GCC Countries Market Share Analysis (%) By Modality, 2022 and 2033
Figure 219: GCC Countries Market Share Analysis (%) By Application, 2022 and 2033
Figure 220: GCC Countries Market Share Analysis (%) By End User, 2022 and 2033
Figure 221: Türkiye Market Value Proportion Analysis, 2022
Figure 222: Global Vs. Türkiye Growth Comparison, 2022 to 2033
Figure 223: Türkiye Market Share Analysis (%) By Modality, 2022 and 2033
Figure 224: Türkiye Market Share Analysis (%) By Application, 2022 and 2033
Figure 225: Türkiye Market Share Analysis (%) By End User, 2022 and 2033
Figure 226: South Africa Market Value Proportion Analysis, 2022
Figure 227: Global Vs. South Africa Growth Comparison, 2022 to 2033
Figure 228: South Africa Market Share Analysis (%) By Modality, 2022 and 2033
Figure 229: South Africa Market Share Analysis (%) By Application, 2022 and 2033
Figure 230: South Africa Market Share Analysis (%) By End User, 2022 and 2033
Figure 231: Northern Africa Market Value Proportion Analysis, 2022
Figure 232: Global Vs Northern Africa Growth Comparison, 2022 to 2033
Figure 233: Northern Africa Market Share Analysis (%) By Modality, 2022 and 2033
Figure 234: Northern Africa Market Share Analysis (%) By Application, 2022 and 2033
Figure 235: Northern Africa Market Share Analysis (%) By End User, 2022 and 2033
The overall market size for Molecular Breast Imaging market was USD 637 Million in 2025.
The Molecular Breast Imaging market is expected to reach USD 970.24 Million in 2035.
The demand for molecular breast imaging will rise due to increasing breast cancer cases, need for early and accurate diagnostics, advancements in dual-head camera technology, and growing adoption in specialized care centers.
The top 5 countries which drives the development of Molecular Breast Imaging market are USA, European Union, Japan, South Korea and UK
Dual Head Camera Systems demand supplier to command significant share over the assessment period.
Explore Similar Insights
Molecular Breast Imaging Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
